4 min of reading 
0 comments 
Researchers at the University of Cambridge have taken an important step towards the future of medicine by initiating the first human trials of a vaccine created with the help of artificial intelligence (AI). The technology aims to protect against various coronaviruses at the same time and could accelerate the development of vaccines for future global threats.
Furthermore, the initiative marks a new stage in the application of AI in the healthcare field. Instead of relying solely on traditional research methods, scientists used advanced algorithms to identify genetic patterns shared among different viruses.
Artificial intelligence helped design the vaccine
To develop the vaccine, the team analyzed thousands of genetic sequences of known coronaviruses. Then, the algorithms identified common characteristics among these viruses and created a structure capable of stimulating a broader immune response.
Thus, the vaccine does not focus solely on a specific variant. On the contrary, it prepares the body to recognize elements present in various coronaviruses of the same family.
-
Only 28% of the ocean floor has been accurately mapped, less than what is already known about the surface of Mars and the Moon, and scientists consider the topic strategic for Brazil, with a global goal to map everything by 2030.
-
Japan wants to bury a 500 km “cargo conveyor” between Tokyo and Osaka to replace up to 25,000 trucks per day, move goods through tunnels and automated driverless corridors, and avoid a logistical collapse in an increasingly aging country.
-
Vietnam dumps sand in the South China Sea and transforms disputed reefs into artificial islands with an area equivalent to more than 1,500 football fields, builds 15 ports in the Spratly Islands, and expands bases in the ocean while challenging Chinese pressure in one of the most tense maritime regions on the planet.
-
Is Rosie from the Jetsons becoming a reality? China tests “robot cleaners” with artificial intelligence inside homes for R$ 114, capable of collecting trash, folding clothes, and mapping apartments, turning domestic cleaning into a living laboratory for companies that want to teach machines to act like humans.
Additionally, the researchers targeted the project at the so-called sarbecoviruses, a group that includes SARS-CoV-2, responsible for Covid-19, as well as the SARS virus and other coronaviruses found in animals.
Initial results show safety
The researchers recruited 39 healthy volunteers for the initial phase of the study. In this stage, the team primarily assessed the safety of the vaccine and observed how the body would react to the new technology.
The results indicated good tolerability among the participants. Additionally, the volunteers developed immune responses against different coronaviruses, including some that do not yet circulate among humans.
Although the team recorded moderate immune responses, the scientists considered the results positive, as the main goal of this phase was to prove the safety of the vaccine.
Objective is to anticipate future threats
Currently, scientists need to update vaccines against viruses that frequently mutate. However, the new approach seeks to overcome this challenge.
Instead of reacting to the emergence of new variants, the technology tries to anticipate possible viral changes. Thus, the vaccine can offer broader and longer-lasting protection.
Furthermore, this strategy can reduce the time needed to respond to future epidemics and pandemics. As a result, health authorities could act more quickly in the face of new threats.
Technology can accelerate medical discoveries
Artificial intelligence played a fundamental role throughout the development process.
While conventional methods require years of analysis, algorithms can examine enormous amounts of data in much shorter periods. In this way, researchers identify potential vaccine targets more quickly and accurately.
Moreover, AI helps find genetic regions that remain stable even when viruses evolve. Therefore, the technology increases the chances of creating vaccines capable of maintaining efficacy for longer.
Applications go beyond coronaviruses
Scientists believe that the same methodology could contribute to the development of vaccines against other infectious diseases.
For example, researchers are already studying applications aimed at viruses like Ebola, influenza, and MERS. Additionally, the technology can help combat pathogens that do not yet pose an immediate risk to the human population.
Consequently, artificial intelligence can become a strategic tool in preventing future health crises.
New phase of testing has already begun
After the initial results, the team started a new stage of clinical studies. Now, about 200 participants will receive the vaccine so that researchers can more accurately assess its effectiveness.
In addition, the scientists intend to refine the algorithms used in the project. In this way, they hope to enhance the protective capacity of the vaccine and improve its immune response.
Advance could transform medicine
The arrival of the first AI-designed vaccine to human testing represents a milestone for science.
Furthermore, the study demonstrates how the combination of biotechnology and AI can accelerate medical discoveries and expand the ability to respond to new diseases. Although the research is still ongoing, the initial results indicate that artificial intelligence could play an increasingly important role in the creation of vaccines and treatments in the future.
Finally, if the next tests confirm the technology’s effectiveness, medicine may count on a new generation of vaccines capable of protecting the population against threats that have not yet emerged.
Be the first to react!